Skip to main content

Medicare Part B Precert Expansion Cimerli (Healthy Blue + Medicare HMO D-SNP)

Please note, this communication applies to Healthy Blue + MedicareSM (HMO D-SNP) offered by Blue Cross and Blue Shield of North Carolina.

Effective for dates of service on and after March 1, 2023, the specialty Medicare part B drug listed in the table below will be included in our precertification review process. 

Federal and state law, as well as state contract language and CMS guidelines, including definitions and specific contract provisions/exclusions, take precedence over these precertification rules and must be considered first when determining coverage. Noncompliance with new requirements may result in denied claims

HCPCS or CPT® code(s): J3590

Medicare part B drugs: Cimerli (ranibizumab-cqrn)

For more information, visit Healthy Blue + Medicare.

NCBCBS-CR-10646-22 October 2022